IRIS
LANNI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.402
AS - Asia 5.544
EU - Europa 4.893
SA - Sud America 723
Continente sconosciuto - Info sul continente non disponibili 268
AF - Africa 155
OC - Oceania 19
Totale 19.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.230
CN - Cina 2.787
SG - Singapore 1.217
IE - Irlanda 1.174
UA - Ucraina 706
DE - Germania 598
HK - Hong Kong 585
FI - Finlandia 533
BR - Brasile 530
IT - Italia 499
RU - Federazione Russa 450
VN - Vietnam 414
FR - Francia 347
GB - Regno Unito 236
SE - Svezia 167
IN - India 130
CA - Canada 84
ZA - Sudafrica 80
AR - Argentina 75
BD - Bangladesh 73
JP - Giappone 53
MX - Messico 45
PK - Pakistan 34
EC - Ecuador 31
IQ - Iraq 29
TR - Turchia 27
ES - Italia 26
NL - Olanda 26
CO - Colombia 24
ID - Indonesia 24
PL - Polonia 21
BE - Belgio 20
SA - Arabia Saudita 19
VE - Venezuela 19
PH - Filippine 16
UZ - Uzbekistan 16
AT - Austria 15
MY - Malesia 15
TN - Tunisia 14
NZ - Nuova Zelanda 13
PE - Perù 12
CZ - Repubblica Ceca 11
JM - Giamaica 11
PY - Paraguay 11
AZ - Azerbaigian 10
CL - Cile 10
IR - Iran 10
JO - Giordania 10
CR - Costa Rica 9
MA - Marocco 9
PT - Portogallo 9
DZ - Algeria 8
EG - Egitto 8
NP - Nepal 8
KE - Kenya 7
KR - Corea 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
IL - Israele 6
LT - Lituania 6
OM - Oman 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
MD - Moldavia 5
MU - Mauritius 5
TH - Thailandia 5
AL - Albania 4
BH - Bahrain 4
CG - Congo 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LB - Libano 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
BG - Bulgaria 2
BJ - Benin 2
BY - Bielorussia 2
GT - Guatemala 2
HU - Ungheria 2
IS - Islanda 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
MN - Mongolia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 18.715
Salva come PNG Salva come JPEG
Città #
Dublin 1.171
Chandler 997
Jacksonville 828
San Jose 749
Singapore 636
Ashburn 595
Nanjing 579
Hong Kong 575
Beijing 446
Dallas 367
Boardman 311
Nanchang 251
Council Bluffs 222
Shenyang 201
Princeton 196
Lawrence 191
Medford 187
Lauterbourg 165
Los Angeles 164
Wilmington 164
Helsinki 160
Jiaxing 144
Hebei 142
Changsha 141
Munich 140
Ho Chi Minh City 130
Tianjin 114
Pavia 109
Hangzhou 92
New York 92
Shanghai 91
Hanoi 88
Ann Arbor 85
Buffalo 85
Milan 78
Johannesburg 70
Moscow 70
Santa Clara 68
Redondo Beach 66
São Paulo 57
Turku 57
Verona 47
Orem 45
Woodbridge 45
Tokyo 44
Frankfurt am Main 36
Norwalk 35
Chennai 31
Montreal 31
Toronto 30
Falkenstein 26
San Francisco 26
Chicago 25
The Dalles 25
Houston 24
Da Nang 23
London 23
Seattle 23
Washington 23
Guangzhou 21
Manchester 21
Boston 20
Brussels 20
Denver 19
Brooklyn 18
Haiphong 18
Rio de Janeiro 18
Stockholm 18
Des Moines 17
Nuremberg 17
Phoenix 17
Zhengzhou 17
Pune 16
Columbus 15
Tashkent 15
Baghdad 14
Brescia 14
Dearborn 14
Dong Ket 14
Mumbai 14
Rome 14
Warsaw 14
Amsterdam 13
Fairfield 13
Jakarta 13
Kunming 13
Atlanta 12
Dhaka 12
Jeddah 12
Jinan 12
Palmerston North 12
Belo Horizonte 10
Brasília 10
Changchun 10
Guayaquil 10
Lahore 10
Ningbo 10
Rodano 10
Tunis 10
Amman 9
Totale 12.222
Salva come PNG Salva come JPEG
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 202
A composite nanosystem as a potential tool for the local treatment of glioblastoma: Chitosan‐coated solid lipid nanoparticles embedded in electrospun nanofibers 160
Antiradical Activity of Water solubile Components of Common Diet Vegetables 154
A novel pathway based on the recruitment of casein kinase 2 is involved in APP processing following cholinergic stimulation. 147
Beta-amyloid short- and long-term synaptic entanglement 146
Anti-hydroxyl radical activity of common edible vegetables 143
Advances in understanding the pathogenetic mechanisms of Alzheimer's disease 141
Acetylcholinesterase inhibitors: effects on pharmacological regulation of amyloid precursor protein processing 139
Amyloid beta-Protein (Abeta) Assembly: Abeta 1-40 And Abeta 1-42 different behaviour in the aggregation process 138
Depression and antidepressants: molecular and cellular aspects. 133
Anti-hydroxyl radical activity of common edible vegetables 133
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers 131
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 130
COGNITION ENHANCERS BETWEEN TREATING AND DOPING THE MIND 129
Characterization of the antioxidant effects of γ-oryzanol: Involvement of the Nrf2 Pathway 129
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 127
Depressione: le nuove ipotesi sulle basi biologiche e il razionale di impiego e sviluppo dei farmaci antidepressivi 127
Antiradical activity of vegetables commonly included in the mediterranean diet 127
DNA damage accumulation and efficiency of DNA repair process in Down syndrome cell model systems 126
Appreciation of functional rather than lesional effects of beta amyloid (AB): a study on dopamine release following in vivo AB infusion 124
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. 124
Acetylcholinesterase inhibitors modulate the metabolism of the amyloid precursor protein via different cellular mechanisms. 124
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens 124
Derivati antracenedionici e aza-antracenedionici come agenti capaci di inibire l’aggregazione di peptidi beta amiloidi 123
Acetylcholinesterase inhibitors: novel activities of old molecules 120
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? 118
Role of b-amyloid in the pathophysiology of Alzheimer’s disease and cholinesterase inhibition: facing the biological complexity to treat the disease. 118
APP processing: some details of downstream cholinergic stimulation. 117
Dehydroepiandrosterone and cortisol: effects on GNB2L1 human promoter region coding for RACK-1 scaffold protein. 117
Altered DNA damage response in Down syndrome cells 117
A novel composite nanosystem as a potential tool for the local treatment of glioblastoma. 116
Alterazioni vascolari e demenza: considerazioni sui possibili meccanismi biologici 116
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing 116
Prenylated curcumin analogues as multipotent tools to tackle Alzheimer's disease 116
Alzheimer's disease: new diagnostic and therapeutic tools 115
Dopare il cervello 114
Dangerous liaisons between Beta-amyloid and cholinergic neurotransmission” 114
Attività antiradicalica del caffè verde e tostato 113
Studies on neuroprotective strategy based on the Amyloid Cascade Hypothesis 113
APP intracellular C-terminal domain function is related to its degradation process. 112
Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. 112
(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis 112
Zyxin is a novel target for beta-amyloid peptide: characterisation of its role in Alzheimer pathogenesis 111
Presence and passage-dependent loss of biochemical M3-muscarinic receptor function in human detrusor cultured smooth muscle cells 111
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach 111
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 111
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 110
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. 109
Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone 109
Regulation amyloid precursor protein processing: nicotinic component of galantamine 108
Alternative views on beta amyloid: a disease target or a cell neuromodulator at the edge between signalling and degeneration. 108
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease. 108
Galantamine: effect on the pharmacological regulation of the amyloid B precursor protein processing 107
Modulation of Rack-1/PKCβII signalling by soluble AβPPα in SH-SY5Y cells. 107
Wild type but not mutant APP is involved in protective adaptive responses against oxidants. 106
Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. 105
In vitro and ex vivo antihydroxyl radical activity of green and dark roasted coffee 105
Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic Orchestra. 105
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 104
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 103
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression 103
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 103
Different Effects of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampus 102
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? 102
Zyxin is a novel target for beta-amyloid peptide: characterization of its role in Alzheimer pathogenesis. 102
Capillary electrophoresis separation of metastable intermediates of amyloid protein fibrillogenesis to use them as independent targets for small molecules. 102
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease 102
Role of acetylcholinesterase inhibitors in the pharmacological regulation of amyloid precursor protein processing 101
Conformational mutant isoform of p53 in blood peripheral cells: a putative marker for Alzheimer's disease 101
Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence. 101
Nature-inspired Nrf2 activators in retinal pigment epithelial cells: a source for therapeutics in Age-related Macular Degeneration 101
Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence 101
Galantamina, razionale farmacologico 100
Transizione conformazionale di proteine fibrillari e neurodegenerazione 99
Discovery of Abeta protein fibrillogenesis inhibitors by using CE. 99
Beta amyloid infusion impairs dopamine release in the nucleus accumbens. 99
Emerging aspects of Alzheimer's disease (AD) pharmacotherapy and relationships with the underlying pathogenetic mechanisms 99
Culture primarie di muscolatura liscia di vescica come tool farmacologico per lo studio della trasmissione delle vie colinergiche nell'uomo. 99
Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways 99
PCK alfa recruitment of neural Elav proteins: implication for mRNA stability and translation 98
Basi neurobiologiche del ritardo mentale 98
Galantamina: il farmaco e il contesto 98
Transcriptional regulation of RACK1 and modulation of its expression: Role of steroid hormones and significance in health and aging 98
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. 98
Effect of beta-amyloid infusion on dopamine release in limbic and motor dopaminergic areas 97
Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells 96
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 96
Unfolded p53: a potential biomarker for Alzheimer's disease 95
Conformational mutant p53 isoform: a novel Alzheimer’s disease marker? 95
Capillary electrophoresis studies on the aggregation process of abeta 1-42 and abeta 1-40 peptides 95
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? 95
Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. 95
Eye-Light on Age-Related Macular Degeneration: Targeting Nrf2-Pathway as a Novel Therapeutic Strategy for Retinal Pigment Epithelium 95
Nuove strategie terapeutiche nella demenza di Alzheimer 94
Attività antiradicalica dei componenti idrosolubili dei semi di Coffea robusta tostati 94
Role of protein kinase C alfa in the regulated metabolism of the amyloid precursor protein 94
Identification of a conformational mutant isoform of P53 in fibroblasts from sporadic Alzheimer¿s disease patients 94
Antoxidant activities of coffee and common diet vegetables: some suggestions for a healthy aging 94
PKC alpha/ELAV-LIKE PROTEINS/GAP-43: A NEW CASCADE OF ACTIVATION IN SH-SY5Y CELLS 94
New nature-inspired hybrids targeting the Nrf2-HO1 pathway protect retinal pigment epithelial cells under stress conditions. 94
Totale 11.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022881 0 2 21 5 7 31 8 49 46 10 131 571
2022/20233.050 299 215 23 211 307 323 1 164 1.376 8 89 34
2023/2024995 126 161 40 100 104 224 24 78 9 66 27 36
2024/20252.660 51 248 80 98 42 145 92 214 631 85 310 664
2025/20265.877 478 427 619 654 705 339 1.136 243 493 478 189 116
2026/2027317 117 200 0 0 0 0 0 0 0 0 0 0
Totale 19.004